Abstract

This seminar explores the evolving role of “value” in shaping the nextGEN of Health Technology Assessment (HTA) mechanisms. Prof. Manuel Espinoza will provide a conceptual foundation, examining the philosophy and meaning of value in HTA, and positioning cost-effectiveness as a principled tool for value-based decision-making. Dr. Tina Wang will bring a practical perspective, drawing on international experiences to illustrate how value frameworks are operationalized across jurisdictions and what core building blocks are needed for robust HTA systems. Together, the session offers both conceptual clarity and applied insights to guide future HTA development.

Speakers

Prof. Manuel Espinoza
Associate Professor
Division of Health Economics, Policy and Management, School of Public Health, HKUMed
https://sph.hku.hk/en/Biography/Espinoza-Manuel-Antonio

Topic: From Philosophy to Practice: Examining the meaning of ‘Value’ in Health technology assessment

Key points:  

• Historical synthetical perspective of the concept  of value
• How we should understand value in health and healthcare
• How we can define a value framework for Hong Kong
• The role of HTA in characterizing value and opportunities  to implement value-based purchasing

Dr. Tina Wang
Associate Director (HTA programme and Strategic Partnership)
Centre for Innovation in Regulatory Science (CIRS)

Topic: HTA Policies and Practices Across Key Jurisdictions: Ensuring Quality Decision Making and Building an Ecosystem for Timely Access to Innovative Medicines.

Key themes included:

• Global comparison of HTA policies and procedures
• Key factors influencing drug rollout
• Good decision making from both agency and company perspectives
• An ecosystem perspective linking development, regulatory review, HTA, and access
•  
• Register Now!